Nutrition & DietVideo Summary

Beta-Hydroxybutyrate May Outperform NAD+ as a Longevity Metabolite

Thomas DeLauer and Dr. Jacob Torres explore why bHB, the ketone body, may be the most powerful metabolic signaling molecule for aging adults.

Friday, June 26, 2026 2 views
Published in Thomas DeLauer
YouTube thumbnail: Beta-Hydroxybutyrate May Outperform NAD+ as a Longevity Metabolite

Summary

This video examines beta-hydroxybutyrate (bHB), a ketone body produced during fasting or ketogenic eating, arguing it may surpass NAD+ as a longevity-relevant metabolic compound. Thomas DeLauer and Dr. Jacob Torres cover how bHB acts not just as fuel but as an epigenetic signal, influencing gene expression through a process called acylation. They discuss its anti-inflammatory properties, its role in gut barrier integrity, kidney health, and heart function. The conversation also explores practical protocols for people over 40, comparing intermittent ketosis versus exogenous ketone supplementation. Niacin's relationship with bHB and fat mobilization is also unpacked, along with why blood ketone meters may underreport tissue-level ketone activity.

Detailed Summary

Beta-hydroxybutyrate (bHB) has long been understood as a fuel source during fasting or low-carbohydrate eating, but emerging research suggests it functions far beyond simple energy metabolism. This video, featuring longevity-focused practitioner Dr. Jacob Torres, frames bHB as a master metabolic signaling molecule that may rival or exceed NAD+ in biological importance for healthy aging.

A central theme is bHB's role as an epigenetic modifier. Through a process called bHB acylation, ketone bodies can attach to histone proteins and influence which genes are expressed — a mechanism that connects dietary patterns directly to cellular aging processes. This positions intermittent ketosis not just as a weight management tool but as a potential longevity intervention at the genomic level.

The video also explores the organ-level effects of bHB, particularly in the kidneys and gut. When kidney function is compromised, downstream gut dysbiosis can follow. bHB and butyrate — a related short-chain fatty acid produced by gut bacteria from soluble fiber — both appear to support gut barrier integrity and reduce systemic inflammation. The kidney-gut feedback loop is presented as an underappreciated axis in metabolic health.

Niacin's interaction with bHB adds nuance: both molecules share receptor pathways that can blunt fat mobilization, raising questions about whether niacin supplementation or high-dose niacin in energy drinks might interfere with ketone-driven fat loss. The hosts clarify that tissue-level bHB effects often go unmeasured by standard blood ketone meters, meaning the metabolic benefits of ketosis may be underestimated in practice.

For actionable guidance, the video targets adults over 40, recommending consideration of intermittent ketosis over continuous supplementation, while distinguishing between ketone salts, esters, and butanediol in terms of safety and efficacy. These insights are clinically relevant for anyone using metabolic strategies to extend healthspan.

Key Findings

  • bHB acts as an epigenetic signal via histone acylation, potentially influencing gene expression tied to aging.
  • Blood ketone meters may underestimate tissue-level bHB activity, making metabolic benefits hard to track.
  • Niacin shares receptor pathways with bHB and may blunt fat mobilization when combined with ketogenic protocols.
  • bHB supports gut barrier integrity and reduces inflammation, partly through the kidney-gut feedback axis.
  • Ketone esters, salts, and butanediol differ significantly in safety and efficacy — protocol choice matters for adults over 40.

Methodology

This is a long-form expert interview hosted by Thomas DeLauer, a high-profile fitness and nutrition YouTuber with a large health-conscious audience. Dr. Jacob Torres appears as a guest practitioner. The video runs approximately 40 minutes and uses timestamped segments covering biochemistry, organ systems, and practical protocols.

Study Limitations

This summary is based on the video description and timestamps only — no transcript was available, so specific claims, cited studies, and Dr. Torres' exact arguments could not be verified. Viewers should cross-reference bHB acylation and kidney-gut axis claims with peer-reviewed literature before clinical application. Thomas DeLauer's content is generally research-informed but is not a substitute for primary sources or medical consultation.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: